Performance Evaluation of the QIAstat-Dx ® Respiratory SARS-CoV-2 Panel

Early identification of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection enables rapid isolation to prevent transmission (European Centre for Disease Prevention and Control, National Institutes of Health, 2020, The World Health Organization). Symptoms of coronavirus disease 2019 (COVID-19) are common to a range of respiratory pathogens; therefore, accurate diagnostics are required for differential diagnosis.

https://www.ijidonline.com/article/S1201-9712(21)00378-7/fulltext?rss=yes

Source: International Journal of Infectious Diseases - April 23, 2021 Category: Infectious Diseases Authors: Samuel Lebourgeois, Alexandre Storto, Bernard Gout, Quentin Le Hingrat, Gustave Ardila Tjader, Maria del Carmen Cerdan, Alistair English, Josep Pareja, Joanna Love, Nadhira Houhou-Fidouh, Davide Manissero, Diane Descamps, Benoit Visseaux Source Type: research